This finding suggests that not only Langerhan cells may have an anti-inflammatory role in psoriasis but also that TNF-α inhibition may restore Langerhan cell migration to epidermis.[60] It is currently FDA approved for the treatment of rheumatoid arthritis. Here, TNF is linked to psoriasis.